| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.846 | 11.260 | 16.526 | 27.119 | 25.988 | 29.707 |
| Total Income - EUR | - | - | - | - | 4.846 | 11.260 | 16.526 | 27.119 | 25.988 | 29.707 |
| Total Expenses - EUR | - | - | - | - | 381 | 2.807 | 5.202 | 11.896 | 16.673 | 15.991 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.465 | 8.452 | 11.324 | 15.224 | 9.315 | 13.715 |
| Net Profit/Loss - EUR | - | - | - | - | 4.320 | 8.114 | 10.828 | 14.834 | 9.056 | 12.824 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Medicina Constienta S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 1.434 | 1.245 | 1.048 | 7.991 |
| Current Assets | - | - | - | - | 4.617 | 12.507 | 13.614 | 15.185 | 39.552 | 20.969 |
| Inventories | - | - | - | - | 0 | 0 | 49 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 5.481 | 9.044 | 687 | 0 |
| Cash | - | - | - | - | 4.617 | 12.507 | 8.084 | 6.141 | 38.865 | 20.969 |
| Shareholders Funds | - | - | - | - | 4.362 | 12.393 | 11.019 | 15.026 | 15.020 | 27.760 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 256 | 114 | 4.029 | 1.404 | 25.580 | 1.199 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicina Constienta S.r.l.